Regio- and Stereoselectivity of Water Elimination
J . Org. Chem., Vol. 62, No. 23, 1997 8061
of the Z-isomer 5a in square brackets); 13C NMR (CDCl3): δ
175.3, [174.9], [150.4], 138.4, [136.7], [128.4], 127.2, [122.9],
[60.3], 60.2, [60.0], 45.5, [40.8], [34.2], [33.4], [33.3], 30.0, [29.8],
[29.1], 28.6, [28.2], 28.11, 28.08, 27.94, 27.87, 27.7, [27.6],
27.39, [27.36], [27.33], [27.28], [27.2], [27.14], 27.07, 27.04,
[26.97], 26.9, [26.75], [26.69], [26.65], 26.4, 26.3, [26.04],
[25.98], [25.6], 25.4, 16.9, [15.5], 14.2, (recognizable signals of
the semicyclic and Z-isomers 3a and 5a in square brackets);
IR (neat) 2928 (vs), 2857 (s), 1735 (s), 1461 (m), 1180 (m); MS
(EI) m/z (rel int) 323 (M + 1, 6), 322 (M+, 26), 102 (100), 97
(35), 95 (31), 83 (43), 81 (35), 69 (35), 67 (39), 55 (47), 41 (38);
HRMS (EI) calcd for C21H38O2 322.2872, found 322.2866.
[23.51], 22.9, [22.6], 17.0, [15.4], [14.7], 14.2, [14.1] (recogniz-
able signals of the semicyclic and Z-isomers 3 and 5a in square
brackets); IR (neat) 2931 (vs), 2860 (s), 1735 (vs), 1468 (m),
1446 (m), 1373 (m), 1180 (s), 1096 (m), 916 (w); MS (EI) m/z
(rel int) 252 (M + 1, 3), 237 (3), 168 (19), 125 (26), 111 (32),
102 (92), 98 (28), 97 (26), 95 (35), 92 (65), 91 (100), 69 (40), 67
(39), 58 (46), 55 (86), 43 (72), 41 (61), 39 (37); HRMS (EI) calcd
for C16H28O2 252.2089, found 252.2087.
(E)-Eth yl 2-(Cyclod ec-1-en yl)p r op ion a te (4g). Ethyl
2-(1-hydroxycyclodecyl)propionate (1g) (1.8 g, 7.0 mmol), after
distillation at 1.9 × 10-2 mmHg, furnished 1.3 g (79%) of 4g
as a colorless oil; bp, 84 °C (1.9 × 10-2 mmHg); 1H NMR
(CDCl3) δ 5.34 (t, J ) 7 Hz, 1H), 4.17-4.08 (m, 2H), 3.06 (q, J
) 7 Hz, 1H), 2.29-2.26 (m, 4H), 1.57-1.51 (m, 4H), 1.40-
1.21 (m, 14H).; 13C NMR (CDCl3) δ 175.4, 137.7, 127.4, 60.3,
43.9, 27.9, 27.4, 26.8, 26.7, 25.2, 24.6, 20.9, 20.7, 16.8, 14.2;
IR (neat) 3510 (vs), 2920 (vs), 1705 (vs), 1470 (vs), 770 (vs);
MS (EI) m/z (rel int) 238 (M+, 0.4), 223 (2), 102 (100), 95 (25),
81 (30), 67 (25), 55 (31), 41 (36); HRMS (EI) calcd for C15H26O2
238.1933, found 238.1935.
(E)-Eth yl 2-(Cyclon on -1-en yl)-p r op ion a te (4h ). Accord-
ing to the general procedure, ethyl 2-(1-hydroxycyclononyl)-
propionate (1h ) (4.5 g, 19 mmol), after distillation at 2 × 10-2
mmHg, yielded 4h (3.1 g, 14 mmol, 74%) as a colorless oil; bp,
74-76 °C (2 × 10-2 mmHg); 1H NMR (CDCl3) δ 5.43 (t, J ) 8
Hz), 4.16-4.08 (m, 2H), 3.07 (q, J ) 7 Hz, 1H), 2.21-2.12 (m,
4H), 1.51-1.45 (m, 10H), 1.62-1.22 (m, 6H); 13C NMR (CDCl3)
δ 175.2, [170.4], [152.2], 139.2, 127.2, [123.7], 60.3, [60.0], 46.9,
[35.5], [35.1], 29.1, [28.6], [28.3], [27.1], 26.8, 26.7, 26.6, [26.4],
26.2, [25.8], 25.5, 24.0, 16.6, [14.3], 14.2 (recognizable signals
of the semicyclic isomer 3 in square brackets); IR (neat) 2977
(s), 2929 (vs), 2862 (s), 1734 (vs), 1451 (m), 1180 (s); MS (EI)
m/z (rel int) 224 (M+, 1), 209 (3), 102 (100), 95 (33), 81 (40), 67
(32), 55 (27), 41 (32); HRMS (EI) calcd for C14H24O2 224.1776,
found 224.1765.
(E)-Eth yl 2-(Cyclopen tadec-1-en yl)pr opion ate (4b). Eth-
yl 2-(1-hydroxycyclopentadecyl)propionate (1b ) (3.8 g, 12
mmol), after distillation at 1.8 × 10-2 mmHg, furnished 2.5 g
(67%) of 4b as a colorless oil; bp 138-142 °C (1.8 × 10-2
1
mmHg); H NMR (CDCl3) δ 5.31 (t, J ) 7 Hz, 1H), [5.22 (t, J
) 7 Hz, 1H)], 4.20-4.06 (m, 2H), 3.05 (q, J ) 7 Hz, 1H), 2.17-
2.00 (m, 8H), 1.37-1.20 (m, 24H), (recognizable signals of the
Z-isomer 5b in square brackets); 13C NMR (CDCl3) δ 175.1,
[174.7], [169.8], [150.9], 138.3, [136.5], [127.7], 127.3, [122.7],
60.1, [59.8], 45.8, [40.7], [34.3], [33.5], 29.5, [28.9], 28.0, [27.8],
[27.6], 27.4, 27.3, [27.24], 27.17, [27.00], 26.96, [26.93], [26.87],
[26.81], 26.76, [26.7], 26.59, 26.56, [26.5], [26.4], 26.22, 26.17,
26.1, [26.0], 25.8, [25.7], [25.6], 16.6, [14.14], [14.08], 14.0
(recognizable signals of the semicyclic and Z-isomer 3b and
5b in square brackets); IR (neat) 2931 (vs), 2858 (vs), 1779
(m), 1735 (vs), 1459 (s), 1181 (s). MS (EI) m/z (rel int) 309 (M
+ 1, 6), 308 (M+, 28), 293 (9), 102 (100), 97 (35), 83 (43), 69
(38), 55 (42), 41 (48). C20H36O2 (308.50) calcd C 77.87, H 11.76,
found C 78.00, H 11.51.
(E)-Eth yl 2-(Cyclotr id ec-1-en yl)p r op ion a te (4d ). Ethyl
2-(1-hydroxycyclotridecyl)propionate (1d ) (1.7 g, 5.7 mmol)
yielded 4d (1.2 g, 75%) as a colorless oil. 1H NMR (CDCl3) δ
5.22-5.13 (m, 1H), 4.12-3.97 (m, 2H), [3.43 (q, J ) 7 Hz, 1H)],
2.98 (q, J ) 7 Hz, 1H), 2.04-1.93 (m, 4H), 1.44-1.12 (m, 24H)
(recognizable signals of the Z-isomer 5a in square brackets);
13C NMR (CDCl3) δ 175.1, [174.6], [169.8], [150.2], 138.7,
[136.2], [128.9], 127.7, [123.0], [60.2], 60.1, 45.5, [41.9], [31.2],
28.2, [28.0], 27.6, [27.1], [26.9], 26.7, 26.6, [26.4], 26.2 (double
intensity), 26.1, [25.9], [25.84], 25.78, 25.72, [25.68], [25.6],
25.4, 24.81, [24.77], [24.7], [24.6], [24.4], [24.3], [23.2], 16.6,
[15.1], 14.0 (recognizable signals of the semicyclic and Z-
isomers 3 and 5a in square brackets); IR (neat) 2927 (vs), 2855
(vs), 1734 (vs), 1461 (s), 1179 (vs), 1097 (s).
(E)-Eth yl 2-(Cyclooct-1-en yl)p r op ion a te (4i). According
to the general procedure, ethyl 2-(1-hydroxycyclooctyl)propi-
onate (1i) (22.8 g, 99 mmol), after distillation at 1.8 × 10-2
mmHg, yielded 4i (15.1 g, 72 mmol, 73%) as a colorless oil;
1
bp, 70 °C (1.8 × 10-2 mmHg); H NMR (CDCl3) δ 5.52 (t, J )
8 Hz, 1H), 4.11 (q, J ) 7 Hz, 2H), 3.09 (q, J ) 7 Hz, 1H), 2.23-
2.09 (m, 4H), 1.56-1.42 (m, 6H), 1.26-1.22 (m, 8H); 13C NMR
(CDCl3) δ 175.1, [151.5], 139.3, 126.6, [123.9], 60.3, 47.1, 29.6,
29.2, 27.8, 26.4, 26.3, 26.2, 16.4, 14.2 (recognizable signals of
the semicyclic isomer 3 in square brackets); IR (neat) 2980
(s), 2927 (vs), 2854 (s), 1733 (vs), 1650 (w), 1469 (m), 1183 (s);
HRMS (EI) calcd for C13H22O2 210.1620, found 210.1614.
(E)-Eth yl 2-(Cyclod od ec-1-en yl)p r op ion a te (4e). Ethyl
2-(1-hydroxycyclododecyl)propionate (1e) (2.0 g, 7.0 mmol),
after flash chromatography (hexane/diethyl ether 4:1, Rf )
(E)-Eth yl 2-(Cycloh ep t-1-en yl)p r op ion a te (4j). Ethyl
2-(1-hydroxycycloheptyl)propionate (1j) (21.2 g, 99 mmol), after
flash chromatography (pentane/diethyl ether 4:1, Rf ) 0.52),
furnished 13.9 g (72%) of 4j as a colorless oil; 1H NMR (CDCl3)
δ 5.71 (t, J ) 7 Hz, 1H), 4.19-4.08 (m, 2H), 3.07 (q, J ) 7 Hz,
1H), 2.14-2.09 (m, 3H), 1.49-1.43 (m, 3H), 1.31-1.21 (m,
10H); 13C NMR (CDCl3) δ 174.7, [170.1], [150.5], 143.1, 128.6,
[122.6], 60.2, [60.1], 48.7, [33.3], [33.2], 32.6, 30.3, [29.0], [28.6],
28.3, [27.7], 26.9, 26.8, [26.1], 15.8, [15.7], 14.2, [14.1]; (signals
of the semicyclic isomer 3 in square brackets); IR (neat) 2923
(vs), 2855 (vs), 1712 (vs), 1623 (s), 1433 (vs), 1276 (vs), 1226
(vs), 1190 (vs), 1113 (vs), 1044 (s), 773 (s); MS (EI) m/z (rel
int) 196 (M+, 3), 182 (97), 151 (100), 150 (52), 125 (48), 123
(24), 122 (38), 101 (27), 96 (28), 95 (36), 93 (33), 88 (25), 83
(50), 82 (30), 81 (90), 79 (40), 77 (24), 67 (82), 55 (78), 54 (20),
53 (22), 43 (28), 41 (43), 39 (34); HRMS (EI) calcd for C12H20O2
196.1463, found 196.1484.
1
0.52), furnished 1.2 g (64%) of 4e as a colorless oil; H NMR
(CDCl3) δ [5.45 (t, J ) 8 Hz, 1H], 5.21 (t, J ) 8 Hz, 1H), 4.08-
3.96 (m, 2H), [3.47 (q, J ) 7 Hz, 1H)], 2.98 (q, J ) 7 Hz, 1H,),
2.13-1.91 (m, 4H), 1.48-1.10 (m, 22H) (recognizable signals
of the Z-isomer 5a in square brackets); 13C NMR (CDCl3) δ
175.1, [174.5], 138.0, [135.2], [129.2], 127.3, [60.1], 59.9, 43.8,
[40.2], [31.4], [27.3], 26.8, 26.3, [26.2], [26.1], 25.1, 24.7, 24.6,
24.5, 24.2, 23.8, [23.6], [23.1], 22.5, 22.1, 16.6, [15.3], 13.9,
[13.8] (recognizable signals of the Z-isomer 5a in square
brackets); IR (neat) 2928 (vs), 2863 (vs), 1735 (vs), 1712 (s),
1600 (w), 1469 (s), 1446 (s), 1180 (vs), 1097 (s), 805 (m), 726
(m); MS (EI) m/z (rel int) 267 (M + 1, 3), 266 (M+, 16), 251 (7),
200 (18), 155 (26), 109 (32), 102 (100), 95 (56), 92 (27), 91 (79),
83 (47), 81 (49), 79 (33), 69 (38), 67 (54), 65 (31), 55 (72), 41
(50); HRMS (EI) calcd for C17H30O2 266.2246, found 266.2231.
(E)-Eth yl 2-(Cycloh ex-1-en yl)p r op ion a te (4k ). Ethyl
2-(1-hydroxycyclohexyl)propionate (1k ) (3.4 g, 17 mmol), after
flash chromatography (pentane/diethyl ether 4:1, Rf ) 0.52),
furnished 2.4 g (76%) of 4k as a colorless oil; 1H NMR (CDCl3)
δ 5.59-5.55 (m, 1H), 4.21-4.10 (m, 2H), 3.02 (q, J ) 7 Hz,
1H), 2.04-1.86 (m, 4H), 1.65-1.52 (m, 4H), 1.33-1.21 (m, 6H);
13C NMR (CDCl3) δ 174.9, 136.6, 123.4, 60.3, 47.1, 26.3, 25.3,
22.9, 22.3, 15.7, 14.3. The compound was mentioned in the
literature24 with no characterization and analytical data.
(E)-Eth yl 2-(Cyclou n d ec-1-en yl)p r op ion a te (4f). Ethyl
2-(1-hydroxycycloundecyl)propionate (1f) (2.0 g, 7.0 mmol),
after distillation at 2.5 × 10-2 mmHg, furnished 1.2 g (64%)
of 4f as a colorless oil; bp, 100 °C (2.5 × 10-2 mmHg); 1H NMR
(CDCl3) δ [5.49 (t, J ) 4 Hz, 1H], 5.24 (t, J ) 7 Hz, 1H), 4.17-
4.07 (m, 2H), [3.67 (q, J ) 7 Hz, 1H], 3.10 (q, J ) 7 Hz, 1H),
2.27-218 (m, 4H), 1.53-1.17 (m, 20H) (recognizable signals
of the Z-isomer 5a in square brackets); 13C NMR (CDCl3) δ
175.4, [174.7], 138.4, [135.7], [127.9], 128.3, [60.4], 60.3, 43.6,
[41.1], [31.1], 29.8, [28.1], 27.9, 27.3, [26.93], 26.88, [26.8],
[26.7], [26.0], 25.8, [25.4], 25.2, [24.9], 24.7, 24.6, [23.66],
(24) Patel, Sh. K.; Paterson, I. Tetrahedron Lett. 1983, 24, 1315.